Correlation Between Innovation Pharmaceuticals and Cytodyn

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovation Pharmaceuticals and Cytodyn at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovation Pharmaceuticals and Cytodyn into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovation Pharmaceuticals and Cytodyn, you can compare the effects of market volatilities on Innovation Pharmaceuticals and Cytodyn and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovation Pharmaceuticals with a short position of Cytodyn. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovation Pharmaceuticals and Cytodyn.

Diversification Opportunities for Innovation Pharmaceuticals and Cytodyn

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Innovation and Cytodyn is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Innovation Pharmaceuticals and Cytodyn in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytodyn and Innovation Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovation Pharmaceuticals are associated (or correlated) with Cytodyn. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytodyn has no effect on the direction of Innovation Pharmaceuticals i.e., Innovation Pharmaceuticals and Cytodyn go up and down completely randomly.

Pair Corralation between Innovation Pharmaceuticals and Cytodyn

Given the investment horizon of 90 days Innovation Pharmaceuticals is expected to generate 10.86 times more return on investment than Cytodyn. However, Innovation Pharmaceuticals is 10.86 times more volatile than Cytodyn. It trades about 0.19 of its potential returns per unit of risk. Cytodyn is currently generating about 0.03 per unit of risk. If you would invest  0.05  in Innovation Pharmaceuticals on September 13, 2024 and sell it today you would lose (0.02) from holding Innovation Pharmaceuticals or give up 40.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Innovation Pharmaceuticals  vs.  Cytodyn

 Performance 
       Timeline  
Innovation Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Innovation Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Innovation Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Cytodyn 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cytodyn has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Innovation Pharmaceuticals and Cytodyn Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovation Pharmaceuticals and Cytodyn

The main advantage of trading using opposite Innovation Pharmaceuticals and Cytodyn positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovation Pharmaceuticals position performs unexpectedly, Cytodyn can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will offset losses from the drop in Cytodyn's long position.
The idea behind Innovation Pharmaceuticals and Cytodyn pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios